• Home
  • Holy Stone Healthcare Co., Ltd.

Holy Stone Healthcare Co., Ltd.

About Holy Stone Healthcare Co., Ltd.

Holy Stone's Hyaluronan Drug Delivery (HDD) technology platform offers partners ready-made targeted and sustained release solutions which are adaptable to multiple drug, peptide or nucleic acid based systems.   Our in house development/GMP manufacturing teams have proven track record of adapting our technologies to suit multiple applications and our in house regulatory expertise works hand in hand to successfully guide candidate products through pre-clinical development, clinical development and beyond.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • TW
  • 2024
    On CPHI since
  • 100 - 249
    Employees
Company types
Pharmaceutical company
View company profile
Contact info
Show contact info Hide contact info

Products from Holy Stone Healthcare Co., Ltd. (4)

  • HDD Technology: Hyaluronan Drug Delivery

    Product HDD Technology: Hyaluronan Drug Delivery

    Holy Stone Healthcare focuses on biopolymers to develop novel drug delivery technologies. Our "Biopolymer drug delivery platform" exploits the biological safety, compatibility, degradability and other characteristics of natural polysaccharides. We have made full use of non-toxic, non-immunogenic, non-infl...
  • Hyaluronic Acid Conjugated Drugs, HACD

    Product Hyaluronic Acid Conjugated Drugs, HACD

    We have developed a “targeting” treatment based on the fact that hyaluronic acid specifically combines with cell surface receptors, glycoprotein CD44 (cluster of differentiation 44) and RHAMM (receptor for hyaluronan mediated motility), which are highly expressed in certain cancer cells. We then select ant...
  • Multi-Layer Coating Pellet Technology (MLCP)

    Product Multi-Layer Coating Pellet Technology (MLCP)

    Multi-layer coating pellet technology (MLCP) is a manufacturing technology developed under the Hyaluronan Drug Delivery technology platform. Using an advanced fluid bed technology, we coat pellets with a patented formulation of drug and HA in multiple layers to produce an oral dosage form targeted to relea...
  • Trans-Mucosal Drug Delivery Technology (TMDD)

    Product Trans-Mucosal Drug Delivery Technology (TMDD)

    Trans-mucosal drug delivery technology is a novel application of hyaluronic acid’s biological, physiological, rheological, and structural properties. By utilizing specific formulations of hyaluronic acid, we have developed products for different indications and with different routes of administration. TMD...

Holy Stone Healthcare Co., Ltd. Resources (1)